Hsp90α/β associates with the GSK3β/axin1/phospho-β-catenin complex in the human MCF-7 epithelial breast cancer model

Biochemical and Biophysical Research Communications

Volumn 413, Issue 4, 2011, Pages 550-554

  Cooper, Leanne C ^a   Prinsloo, Earl ^a   Edkins, Adrienne L ^a   Blatch, Gregory L ^a,b  

^a RHODES UNIVERSITY   (South Africa)

^b VICTORIA UNIVERSITY   (Australia)

Author keywords

Catenin; Axin1; Breast cancer; GSK3 ; Hsp90

Indexed keywords

AXIN; AXIN 1; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90ALPHA; HEAT SHOCK PROTEIN 90BETA; PHOSPHO BETA CATENIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER MODEL; CELL STRAIN MCF 7; COMPLEX FORMATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

AXIN PROTEIN; BETA CATENIN; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; EPITHELIAL CELLS; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HSP90 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOPRECIPITATION; MODELS, BIOLOGICAL; PHOSPHORYLATION;

EID: 80053577848     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.136     Document Type: Article

References (29)

1. Radtke F., Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005, 307:1904-1909.
2. Reya T., Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434:843-850.
3. MacDonald B.T., Tamai K., He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell 2009, 17:9-26.
4. Ikeda S., Kishida S., Yamamoto H., et al. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J. 1998, 17:1371-1384.
5. Ha N.-C., Tonozuka T., Stamos J.L., et al. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. Mol. Cell 2004, 15:511-521.
6. Amit S., Hatzubai A., Birman Y., et al. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway. Genes Dev. 2002, 16:1066-1076.
7. Kimelman D., Xu W. Beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 2006, 25:7482-7491.
8. Davidson G., Wu W., Shen J., et al. Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature 2005, 438:867-872.
9. Zeng X., Tamai K., Doble B., et al. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 2005, 438:873-877.
10. Taelman V.F., Dobrowolski R., Plouhinec J.-L., et al. Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 2010, 143:1136-1148.
11. Whitesell L., Lindquist S.L. HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 2005, 5:761-772.
12. Richter K., Buchner J. Hsp90: chaperoning signal transduction. J. Cell. Physiol. 2001, 188:281-290.
13. Citri A., Harari D., Shohat G., et al. Hsp90 recognizes a common surface on client kinases. J. Biol. Chem. 2006, 281:14361-14369.
14. Lochhead P.A., Kinstrie R., Sibbet G., et al. A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation. Mol. Cell 2006, 24:627-633.
15. Dou F., Chang X., Ma D. Hsp90 maintains the stability and function of the Tau phosphorylating kinase GSK3β. Int. J. Mol. Sci. 2007, 8:51-60.
16. Banz V.M., Medová M., Keogh A., et al. Hsp90 transcriptionally and post-translationally regulates the expression of NDRG1 and maintains the stability of its modifying kinase GSK3beta. Biochim. Biophys. Acta 2009, 1793:1597-1603.
17. Kurashina R., Ohyashiki J., Kobayashi C., et al. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells. Cancer Lett. 2009, 284:62-70.
18. Schlange T., Matsuda Y., Lienhard S., et al. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res. 2007, 9:R63.
19. Ossewaarde J.M., de Vries A., Bestebroer T., et al. Application of a mycoplasma group-specific PCR for monitoring decontamination of Mycoplasma-infected Chlamydia sp. strains. Appl. Environ. Microbiol. 1996, 62:328-331.
20. Manders E.M., Stap J., Brakenhoff G.J., et al. Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy. J. Cell Sci. 1992, 103:857-862.
21. Zinchuk V., Zinchuk O., Okada T. Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena. ACTA Histochem. Cytochem. 2007, 40:101-111.
22. Zinchuk V., Zinchuk O. Quantitative colocalization analysis of confocal fluorescence microscopy images. Curr. Protoc. Cell Biol. 2008, 4. (Unit 4.19).
23. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
24. Tillotson B., Slocum K., Coco J., et al. Hsp90 (heat shock protein 90) inhibitor occupancy is a direct determinant of client protein degradation and tumor growth arrest in vivo. J. Biol. Chem. 2010, 285:39835-39843.
25. Yun B.-G., Huang W., Leach N., et al. Novobiocin induces a distinct conformation of Hsp90 and alters hsp90-cochaperone-client interactions. Biochemistry 2004, 43:8217-8229.
26. Fontana J. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ. Res. 2002, 90:866-873.
27. Jope R.S. Lithium and GSK-3: one inhibitor two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 2003, 24:441-443.
28. S. Piao, S. Lee, H. Kim, et al., Direct inhibition of GSK3beta by the phosphorylated cytoplasmic domain of LRP6 in Wnt/beta-catenin signaling, PLoS One 3 (2008) e4046.
29. G. Wu, H. Huang, J. Garcia Abreu, et al., Inhibition of GSK3 phosphorylation of beta-catenin via phosphorylated PPPSPXS motifs of Wnt coreceptor LRP6, PLoS One 4 (2009) e4926.